Afrezza is BACK! After Sanofi terminated its marketing partnership with MannKind, MannKind has relaunched its fast-acting inhalable insulin, Afrezza, as reported in DiaTribe.org on 30 August, 2016. I, for one, couldn’t be happier and more relieved. ...
A STAR is BORN! Yup, little ‘ol me! Mr. deMille, I’m ready for my close-up!!! OK, enough! I was honored to be asked to be a T1d Co-Host on The Bonnie Sher Show, broadcast on UBN internet radio/tv, on Thursday, 15 September 2016. Bonnie is a long-time...
OK, … this is WAY OUT THERE … or is it? (this is not a recommendation or endorsement) Listen to this podcast from The Pulse, reporting on an Oakland, CA grassroots community lab for biohacking and citizen science. According to their website,...
Commercial airline pilots flying with insulin-controlled diabetes had no incidents of medical incapacitation in more than 18 months of study, researchers reported by the European Association for the Study of Diabetes, 12 September 2016 via MedPageToday.com. The study...
That’s right! I’m on my way to Hollywood! OK, well, kinda! But I’m excited! I’ve been invited to be a T1 Co-Host on The Bonnie Sher Show in Channel 2 of the Universal Broadcast Network (UBN). WHEN: Thursday, September 15, 2016, 2pm -3pm...
Antibiotics Linked to T1D in Mice, according to a study at NYU Langone Medical Center, reported in Nature Microbiology, August 22, 2016 and published in MedPageToday, Endocrinology, August 24, 2016. The study results center on the microbiome, the bacterial species in...